MJManon Jaboyedoff

Manon Jaboyedoff

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manon Jaboyedoff has a total of 161 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidemiology, Early Therapy and Sequelae Predictors in Congenital CMV

    by Renato Gualtieri, Aimilia Tzani, Sebastien Papis, Hélène Cao Van, Manon Jaboyedoff, Yves Fougère, Eric Giannoni, Marie Ballester, Abdelaziz Zemmouri, Michael Russo, et al.

    Background: Congenital cytomegalovirus (cCMV) is the most common congenital infection, with approximately 17%–20% of infected neonates developing permanent sequelae. Early risk stratification remains challenging yet crucial for therapeutic decision-making. We aimed to characterize national epidemiology, identify early predictors of sequelae, and assess the impact of early antiviral treatment on outcomes in infants with cCMV. Methods: We conducted a nationwide prospective observational study between 2017 and 2024, analyzing birth and 1-year follow-up data of infants with confirmed cCMV in Switzerland. Results: Two hundred and nine cCMV-infected children were included. The most common findings at birth were microcephaly (35%), intrauterine growth restriction (34%) and neuroimaging abnormalities (36%). Antiviral treatment was administered to 36% (75/209) of patients, among whom 75% (56/75) had treatment initiation within the first month of life. Multivariate analysis identified hepatosplenomegaly (odds ratio 13.2, 95% confidence interval, 2.3–75.2) and hypotonia at birth (odds ratio 6.6, 95% confidence interval, 1.1–41.1) as independent predictors of late-onset sensorineural hearing loss (SNHL). At the 1-year follow-up assessment, early treatment initiation was associated with significantly lower rates of neurodevelopmental disorders compared with delayed treatment initiation (23% vs. 50%, P = 0.004). Conclusions: This Swiss nationwide study confirms the previously reported association between hepatosplenomegaly at birth and late-onset SNHL and identifies hypotonia as a new independent predictor of late-onset SNHL. The data also confirm the crucial role of early antiviral treatment, particularly for neurodevelopmental disorders, emphasizing the importance of prompt cCMV diagnosis and treatment when indicated.

  • Surgical Antibiotic Prophylaxis Through the ALARA Lens: Data From England

    by Manon Jaboyedoff, Jocelyn Elmes, Cindy Leung Soo, Angus Beattie, Pauline Harrington, Theresa Lamagni, Berit Muller-Pebody, Alicia Demirjian

  • Open Access

    Tintelnotia destructans Invasive Rhinosinusitis in an Immunocompromised Child: A Case Report and Review of the Literature

    by Manon Jaboyedoff, Frederic Lamoth, Claire Bertelli, Jizhou Li, Estelle Dubruc, Frida Rizzati, Antoine Reinhard, Raffaele Renella, Pierre Alex Crisinel

    Tintelnotia destructans is a recently described fungus within the family Phaeosphaeriaceae, previously reported only in superficial human infections such as keratitis, onychomycosis, and noninvasive sinus fungus ball. We describe the first case of invasive rhinosinusal infection due to this pathogen in a child with severe aplastic anemia. Diagnosis was established by histopathology showing submucosal fungal invasion and broad-range fungal polymerase chain reaction targeting 18S rRNA identifying T. destructans. Combined endoscopic surgical debridement, antifungal therapy (liposomal amphotericin B and isavuconazole), and immune reconstitution after emergency haploidentical hematopoietic stem cell transplant ultimately led to complete recovery without recurrence 18 months after treatment, despite continued therapeutic immunosuppression for graft-vs-host disease. This case expands the known pathogenic spectrum of T. destructans, demonstrating its potential to cause invasive disease in severely immunocompromised hosts. Advances in molecular diagnostic tools may expand the spectrum of fungi causing invasive fungal infections by identification of novel pathogenic species.

  • Respiratory Syncytial Virus Shapes Serotype-Specific Invasive Pneumococcal Disease Dynamics in Children: An Observational Study

    by Inès Fafi, Corinne Levy, Emmanuelle Varon, Robert Cohen, Stéphane Béchet, Zaba Valtuille, André Birgy, Stéphane Bonacorsi, Jean-François Delobbe, Christophe Batard, et al.

    Background: Pneumococcal nasopharyngeal colonization is the first step toward invasive pneumococcal disease (IPD). Respiratory syncytial virus (RSV) may trigger IPD, particularly for serotypes with low disease potential. We aimed to analyze the distribution of pneumococcal serotypes among pediatric IPD according to RSV circulation level. Methods: We used data from 3 continuous French surveillance systems on IPD, pneumococcal carriage and RSV infections from 2008 to 2023. Based on the RSV epidemic threshold, we assessed the proportion of each serotype among IPD, depending on “RSV season” and “non-RSV season.” We assessed the correlation between the likelihood of serotype-specific involvement in IPD according to non-RSV season versus RSV season and the estimated disease potential of each serotype. Results: Among 4574 IPD cases, the serotype distribution strongly varied during non-RSV season versus RSV season. The lower the disease potential of serotypes, the more RSV circulation enhanced their involvement in IPD (Rho=0.60, CI95% .28–.80, P = .0012). Conclusions: The role of RSV in triggering IPD strongly varies across pneumococcal serotypes. The impact of RSV-targeted interventions should be evaluated in light of these data.


  • Open Access

    Quantifying the mechanisms of vaccine-induced serotype replacement in Streptococcus pneumoniae using genome-informed modelling

    by Zein Assad, Kevin La, Corinne Levy, Robert Cohen, Assiya El Mniai, Ines Fafi, Zaba Valtuille, Stephane Bechet, Francois Corrard, Andreas Werner, et al.

    Streptococcus pneumoniae is a colonizer of the child s nasopharynx and a leading cause of invasive pneumococcal disease (IPD). Despite widespread use of pneumococcal conjugate vaccines, recent rebounds in IPD incidence have coincided with serotype replacement. Whether this phenomenon is driven by the replacement of serotypes within lineages or the replacement of the lineages themselves is unclear. Here, we quantified the relative contribution of these two mechanisms to serotype replacement in carriage and their consequences for IPD. We combined nationwide longitudinal surveillance of carriage and IPD in children from 2002 to 2023 with whole-genome sequencing. Observed lineage-specific carriage rates across PCV-related periods were fitted with polynomial logistic regression and compared with two counterfactual scenarios, each isolating one mechanism with: (i) fixed serotype composition within varying lineages and (ii) serotype shifts within fixed lineage carriage rates over time. Carriage dynamics were consistent with an 82% contribution of serotype shifts within persistent lineages. Estimates of serotype-specific IPD incidence derived from this predominant scenario correlated with observed IPD trends. These findings quantify the dominant role of serotype replacement within persistent lineages, disentangling the vaccine-driven adaptive history of S. pneumoniae.

  • Open Access

    Quantifying the mechanisms of vaccine-induced serotype replacement in Streptococcus pneumoniae using genome-informed modelling

    by Zein Assad, Kevin La, Corinne Levy, Robert Cohen, Assiya El Mniai, Inès Fafi, Zaba Valtuille, Stéphane Bechet, François Corrard, Andreas Werner, et al.

    Streptococcus pneumoniae is a colonizer of the child’s nasopharynx and a leading cause of invasive pneumococcal disease (IPD). Despite widespread use of pneumococcal conjugate vaccines (PCV), recent rebounds in IPD incidence have coincided with serotype replacement. The relative contribution of the replacement of serotypes within lineages and the replacement of the lineages themselves to this phenomenon is unclear. Yet these two evolutionary mechanisms may affect differently the fitness of S. pneumoniae and have distinct consequences on vaccination strategies. Here, we quantified the relative contribution of these two mechanisms to serotype replacement in carriage and their consequences for IPD. We combined nationwide longitudinal surveillance of carriage in children with acute otitis media and IPD in children from 2002 to 2023 with whole-genome sequencing. Observed lineage-specific carriage rates across PCV-related periods were fitted with polynomial logistic regression and compared with two counterfactual scenarios, each isolating one mechanism: (i) fixed serotype composition within varying lineages and (ii) serotype shifts within fixed lineage carriage rates over time. Carriage dynamics were consistent with an 82% contribution of serotype shifts within persistent lineages. Estimates of serotype-specific IPD incidence derived from this predominant scenario correlated with observed IPD trends. These findings quantify the dominant role of serotype replacement within persistent lineages, disentangling the vaccine-driven adaptive history of S. pneumoniae.

  • Open Access

    Infection-related mortality in children in two European countries, 2015–2023: An interrupted time-series analysis

    by Manon Jaboyedoff, Pierre Alex Crisinel, Zaba Valtuille, Inès Fafi, Margherita Plebani, Yves Fougère, Karim Abawi, Romain Basmaci, Naïm Ouldali, François Angoulvant


  • Open Access

    A 16‐Year‐Old Boy With ARDS and Septic Shock, an Atypical Presentation of Murine Typhus: Case Report and Review of the Literature

    by Pierre H. François, Thalia Leclerc, Manon Jaboyedoff, Onya Opota, Gilbert Greub, Guillaume Maitre, Vivianne Chanez

    Murine typhus is a flea‐borne disease caused by the bacteria Rickettsia typhi that occurs worldwide, but predominantly in endemic areas. The clinical presentation of typhus is often nonspecific, leading to delays in diagnosis and treatment. The severity of the disease varies widely. Most cases are relatively mild, but some patients develop a very severe form and may die. We report a case of severe murine typhus complicated by septic shock, alveolar hemorrhage, and acute respiratory distress syndrome in a teenager who was born in Somalia and had immigrated from Kenya to Switzerland. Diagnosis was suspected upon admission in the pediatric intensive care unit and was confirmed by PCR. The patient improved with doxycycline treatment. Rickettsial disease should be considered in the differential diagnosis of patients returning from endemic areas, and anti‐rickettsial treatment should be started without delay to ensure rapid recovery and avoid severe complications.

  • Impact of SARS-CoV-2 pandemic on Pediatric inpatients with invasive group a streptococcal infections (iGAS): results of a National Survey

    by Zweifel Nils, Güsewell Sabine, Jaboyedoff Manon, Albrich Werner, Aebi Christoph, Niederer-Loher Anita, Kahlert Christian, Swiss Paediatric Surveillance Unit (Spsu)

  • Open Access

    Sustained Increase in Pediatric Mastoiditis in the Post-COVID-19 Era: A 9-Year Interrupted Time-Series Analysis Based on National Data

    by Apolline Furgier, Romain Basmaci, Zaba Valtuille, Inès Fafi, Zein Assad, Léa Lenglart, Natacha Teissier, Charlotte Benoit, Emilien Chebib, Aurélie Bourmaud, et al.